Pharma Focus Asia

Co-processed Microcrystalline Cellulose from University of Antioquia

A team of researchers and specialists at the University of Antioquia have come up with a groundbreaking technology, co-processed microcrystalline cellulose, having usefulness in various sectors including pharmaceuticals, cosmetics and the food industry.

A first-of-its-kind product, co-processed microcrystalline cellulose brings with it novel industrial applications in the pharmaceuticals sector.

Microcrystalline Cellulose is major breakthrough with its unique feature i.e. the cellulose based tablets might bring faster relief in cases of headache. This is because cellulose is found to disintegrate faster after ingestion.

The co-processed microcrystalline cellulose, was arrived at through a two-year long study led by Dr. John J. Rojas at the School of Pharmacy, University of Antioquia. The team of scientists comprised of Isabel C. Henao, Pamela Alvarez and Adriana Pérez, apart from Rojas.

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024